CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Revenue	$ 482,798	$ 15,106	$ 881,929	$ 26,006
Cost of revenue	75,384	52,384	258,801	108,579
Gross Profit (Loss)	407,414	(37,278)	623,128	(82,573)
Operating Expenses:
Research and development	161,194	157,876	399,884	207,504
Research and development - related parties	0	38,767	0	439,824
Selling, general and administrative	461,377	605,473	1,908,635	1,019,835
Total Operating Expenses	622,571	802,116	2,308,519	1,667,163
Loss From Operations	(215,157)	(839,394)	(1,685,391)	(1,749,736)
Other Income (Expense):
Interest (expense) income , net	(269)	142	(502)	(8,114)
Change in fair value of accrued issuable equity	24,175	0	24,175	0
Total Other Income (Expense)	23,906	142	23,673	(8,114)
Net Loss	$ (191,251)	$ (839,252)	$ (1,661,718)	$ (1,757,850)
Net Loss Per Share - Basic and Diluted	$ 0.00	$ (0.01)	$ (0.02)	$ (0.03)
Weighted Average Number of Common Shares Outstanding - Basic and Diluted	77,785,191	76,843,759	77,513,560	59,570,769